Table 1.
Effect of zerumbone treatment on liver enzyme activity and total protein
| Treatment | Mean (SEM) | |||
|---|---|---|---|---|
|
| ||||
| Alanine Aminotransferase (ALT) (IU/L) | Aspartate Amiotransferase (AST) (IU/L) | Serum total protein (g/100 mL) | Hepatic total protein (g/100 mL) | |
| Group I (Control) | 30.18 (7.80) | 40.07 (3.31) | 41.46 (6.27) | 28.68 (4.03) |
| Group II (PCM+PBS) | 58.33 (4.17)a | 66.69 (7.83)a | 52.19 (6.84)a | 45.10 (10.23)a |
| Group III (PCM + ZER 25 mg/kg) | 35.63 (7.66)b | 49.08 (4.34)a,b | 47.24 (4.12) | 21.29 (4.32)a,b |
Values were expressed as mean (SEM)
a
Significantly different from Group I (control group)
b
Significantly different from Group II (group treated with PCM only)